ertapenem

(redirected from Invanz)
Also found in: Medical.
Related to Invanz: vancomycin
Translations

ertapenem

n ertapenem m
References in periodicals archive ?
Pharmaceutical sales growth for the quarter was partially offset by the ongoing impacts from the loss of market exclusivity for ZETIA(ezetimibe) and VYTORIN (ezetimibe/simvastatin), INVANZ (ertapenem sodium) and REMICADE (infliximab).
This increase reflects the third-quarter 2018 launch of ertapenem for injection, the authorized generic of INVANZ, as well as the continued strong growth of VASOSTRICT and ADRENALIN.
M2 PHARMA-July 31, 2018-Generic Version of Invanz Begins Shipping in US
(Invanz ([R]), Merck sharp and Dohme Drugs; USA) once a day was started by Infectious disease department for mediastinitis complication of a ODNI.
The four drugs are Cubicin, indicated for complex skin infections and bloodstream infections, with sales of $1.17 billion; Vytorin, a cholesterol drug that contributes $1.12 billion; Invanz, used to treat a variety of bacterial infections and generating $544 million in sales; and Cancidas, prescribed for treatment of candidemia and other Candida infections, with annual sales of $540 million.
The three major drugs in this area all have side effect issues: Zyvox has been reported to cause myelosuppression, hematological adverse events, and optic neuropathy, whereas Invanz and Zosyn are associated with hypersensitivity reactions, and Invanz has the potential to cause seizures.